10997338|t|Evidence that the beta-catenin nuclear translocation assay allows for measuring presenilin 1 dysfunction.
10997338|a|BACKGROUND: Mutations in the presenilin (PSEN) genes are responsible for the majority of early-onset Alzheimer disease (AD) cases. PSEN1 is a component of a high molecular weight, endoplasmic reticulum, membrane-bound protein complex, including beta-catenin. Pathogenic PSEN1 mutations were demonstrated to have an effect on beta-catenin and glycogen synthase kinase-3beta(GSK-3beta), two members of the wingless Wnt pathway. The nuclear translocation and the stability of beta-catenin, and the interaction between GSK3beta and PSEN1 were influenced. MATERIALS AND METHODS: Stably transfected human embryonic kidney (HEK) 293 cells overexpressing wild-type (wt) and mutant (mt) PSEN1, treated with and without LiCl, were used to isolate cytoplasmic and nuclear fractions. By Western blot analysis, endogenous beta-catenin levels were examined. By analyzing cytosolic fractions of PSEN1, transfected and nontransfected HEK 293 cells, and total brain extracts of AD patients and controls, we evaluated the effect of PSEN1 overexpression on beta-catenin stability. Finally, we analyzed the effect of pathogenic PSEN1 mutations on the interaction between PSEN1 and GSK3beta by co-immunoprecipitation experiments. RESULTS: We report reduced nuclear translocation of beta-catenin in cells stably expressing I143T, G384A, and T113-114ins PSEN1. The G384A PSEN1 mutation showed a similar pronounced effect on nuclear translocation of beta-catenin, as reported for processing of amyloid precursor protein (APP) into amyloid beta(Abeta). Overexpression of PSEN1 and the presence of pathogenic mutations in PSEN1 had no significant effect on the stability of beta-catenin. Nonspecific binding of overexpressed PSEN1 to endogenous GSK3beta was observed when GSK3beta was immunoprecipitated. Immunoprecipitation of PSEN1 in cells overexpressing PSEN1 and in native cells, however, did not result in co-immunoprecipitation of endogenous GSK3beta. CONCLUSION: Our results further establish the nuclear translocation assay of beta-catenin as an adequate alternative for traditional Abeta measurement to evaluate the effect of PSEN1 mutations on biochemical processes. We detected no significant effect of overexpressed wt or mt PSEN1 on the stability of beta-catenin. Finally, co-immunoprecipitation between PSEN1 and GSK3beta was not observed in our experimental setup.
10997338	18	30	beta-catenin	Gene	1499
10997338	80	92	presenilin 1	Gene	5663
10997338	207	224	Alzheimer disease	Disease	MESH:D000544
10997338	226	228	AD	Disease	MESH:D000544
10997338	237	242	PSEN1	Gene	5663
10997338	351	363	beta-catenin	Gene	1499
10997338	376	381	PSEN1	Gene	5663
10997338	431	443	beta-catenin	Gene	1499
10997338	448	478	glycogen synthase kinase-3beta	Gene	2932
10997338	479	488	GSK-3beta	Gene	2932
10997338	579	591	beta-catenin	Gene	1499
10997338	621	629	GSK3beta	Gene	2932
10997338	634	639	PSEN1	Gene	5663
10997338	699	704	human	Species	9606
10997338	723	726	HEK	CellLine	CVCL:M624
10997338	728	731	293	CellLine	CVCL:0045
10997338	784	789	PSEN1	Gene	5663
10997338	816	820	LiCl	Chemical	MESH:D018021
10997338	915	927	beta-catenin	Gene	1499
10997338	986	991	PSEN1	Gene	5663
10997338	1024	1031	HEK 293	CellLine	CVCL:0045
10997338	1067	1069	AD	Disease	MESH:D000544
10997338	1070	1078	patients	Species	9606
10997338	1120	1125	PSEN1	Gene	5663
10997338	1144	1156	beta-catenin	Gene	1499
10997338	1214	1219	PSEN1	Gene	5663
10997338	1257	1262	PSEN1	Gene	5663
10997338	1267	1275	GSK3beta	Gene	2932
10997338	1367	1379	beta-catenin	Gene	1499
10997338	1407	1412	I143T	ProteinMutation	tmVar:p|SUB|I|143|T;HGVS:p.I143T;VariantGroup:1;CorrespondingGene:5663;RS#:63750004;CorrespondingSpecies:9606;CA#:225019
10997338	1414	1419	G384A	ProteinMutation	tmVar:p|SUB|G|384|A;HGVS:p.G384A;VariantGroup:0;CorrespondingGene:5663;RS#:63750646(Expired);CorrespondingSpecies:9606;CA#:225161
10997338	1425	1436	T113-114ins	DNAMutation	tmVar:c|INS|113_114|T;HGVS:c.113_114insT;VariantGroup:2;CorrespondingGene:5663;CorrespondingSpecies:9606
10997338	1437	1442	PSEN1	Gene	5663
10997338	1448	1453	G384A	ProteinMutation	tmVar:p|SUB|G|384|A;HGVS:p.G384A;VariantGroup:0;CorrespondingGene:5663;RS#:63750646(Expired);CorrespondingSpecies:9606;CA#:225161
10997338	1454	1459	PSEN1	Gene	5663
10997338	1532	1544	beta-catenin	Gene	1499
10997338	1576	1601	amyloid precursor protein	Gene	351
10997338	1613	1625	amyloid beta	Gene	351
10997338	1626	1631	Abeta	Gene	351
10997338	1652	1657	PSEN1	Gene	5663
10997338	1702	1707	PSEN1	Gene	5663
10997338	1754	1766	beta-catenin	Gene	1499
10997338	1805	1810	PSEN1	Gene	5663
10997338	1825	1833	GSK3beta	Gene	2932
10997338	1852	1860	GSK3beta	Gene	2932
10997338	1908	1913	PSEN1	Gene	5663
10997338	1938	1943	PSEN1	Gene	5663
10997338	2029	2037	GSK3beta	Gene	2932
10997338	2116	2128	beta-catenin	Gene	1499
10997338	2172	2177	Abeta	Gene	351
10997338	2216	2221	PSEN1	Gene	5663
10997338	2318	2323	PSEN1	Gene	5663
10997338	2344	2356	beta-catenin	Gene	1499
10997338	2398	2403	PSEN1	Gene	5663
10997338	2408	2416	GSK3beta	Gene	2932
10997338	Positive_Correlation	MESH:D000544	RS#:63750004;HGVS:p.I143T;CorrespondingGene:5663
10997338	Positive_Correlation	MESH:D000544	RS#:63750646(Expired);HGVS:p.G384A;CorrespondingGene:5663
10997338	Association	MESH:D000544	351
10997338	Association	351	5663
10997338	Association	MESH:D000544	5663
10997338	Association	2932	5663
10997338	Association	1499	5663
10997338	Association	MESH:D000544	5663

